Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Baricitinib may effectively treat nail changes in alopecia areata.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib may help people with long-term alopecia areata.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.